Chondrosarcoma-from Molecular Pathology to Novel Therapies

SIMPLE SUMMARY: Chondrosarcoma (CHS) belongs to a broad group of sarcomas and is the second most frequent malignant bone tumor. Due to its resistance to chemo- and radiotherapy, treatment of this tumor is complicated and is mainly limited to surgery. In this review, we described the characteristics...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancers (Basel)
Main Authors: Zając, Agnieszka E., Kopeć, Sylwia, Szostakowski, Bartłomiej, Spałek, Mateusz J., Fiedorowicz, Michał, Bylina, Elżbieta, Filipowicz, Paulina, Szumera-Ciećkiewicz, Anna, Tysarowski, Andrzej, Czarnecka, Anna M., Rutkowski, Piotr
Formato: Artigo
Idioma:Inglês
Publicado em: MDPI 2021
Assuntos:
Review
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8155983/
https://ncbi.nlm.nih.gov/pubmed/34069269
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers13102390
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados